AFPGC patients who are HER2 positive are even poorer.<h4>Methods</h4>A single-center retrospective real-world analysis was conducted in patients with histologically confirmed gastric cancer, an AFP level > 7 ng/ml and who were pathologically HER2 positive at Tianjin Medical University Cancer Institute. This evidence concerns the gene ERBB2 and gastric cancer.